Registry for HER2-positive breast cancer patients
Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)
This study is collecting information from people with HER2-positive breast cancer to see how different factors affect their treatment outcomes and overall care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 6 sites (Overland Park, Kansas and 5 other locations) |
| Trial ID | NCT06603597 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on patients with HER2-positive breast cancer to explore the relationships between various patient and tumor characteristics and their outcomes. By collecting and analyzing this information, researchers hope to identify patterns that could inform treatment decisions and improve patient care. The study will include patients at different stages of HER2-positive breast cancer, allowing for a comprehensive understanding of the disease.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with stage I-IV HER2-positive breast cancer.
Not a fit: Patients with other types of breast cancer or those who do not meet the HER2-positive criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and outcomes for patients with HER2-positive breast cancer.
How similar studies have performed: Other observational studies focusing on breast cancer characteristics have shown success in identifying important links that can enhance patient management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Stage I-IV HER2-positive breast cancer Exclusion Criteria: * None
Where this trial is running
Overland Park, Kansas and 5 other locations
- KUCC - Indian Creek — Overland Park, Kansas, United States (Active_not_recruiting)
- KUCC - Overland Park — Overland Park, Kansas, United States (Active_not_recruiting)
- KUCC - Briarcliff — Westwood, Kansas, United States (Active_not_recruiting)
- KUCC - Olathe — Westwood, Kansas, United States (Active_not_recruiting)
- The University of Kansas Cancer Center — Westwood, Kansas, United States (Recruiting)
- KUCC - Lee's Summit — Lee's Summit, Missouri, United States (Active_not_recruiting)
Study contacts
- Study coordinator: Study Coordinator
- Email: PRO-HER2@kumc.edu
- Phone: 913-588-6079
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.